Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE

<strong>Objectives<br></strong> Evaluate the importance of treatment sequencing in SELECT-COMPARE, assessing potential differences between starting upadacitinib or adalimumab therapy following inadequate MTX response. <br><strong> Methods<br></strong> Patien...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Mysler, E, Tanaka, Y, Kavanaugh, A, Aletaha, D, Taylor, PC, Song, I-H, Shaw, T, Song, Y, DeMasi, R, Ali, M, Fleischmann, R
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: Oxford University Press 2022